| scholarly article | Q13442814 |
| P2093 | author name string | Kunwu Yu | |
| Hasahya Tony | |||
| Zeng Qiutang | |||
| P2860 | cites work | Doxorubicin induces apoptosis in Jurkat cells by mitochondria-dependent and mitochondria-independent mechanisms under normoxic and hypoxic conditions. | Q51653643 |
| Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis | Q64378116 | ||
| Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo | Q82518783 | ||
| MicroRNAs: new players in cardiac injury and protection | Q24635236 | ||
| MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction | Q28268501 | ||
| Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine | Q28366936 | ||
| Mechanical stretch via transforming growth factor-β1 activates microRNA208a to regulate endoglin expression in cultured rat cardiac myoblasts | Q28568593 | ||
| Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death | Q28579471 | ||
| A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance | Q29619547 | ||
| Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity | Q30500787 | ||
| Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy | Q34113952 | ||
| Mechanism of anthracycline-mediated down-regulation of GATA4 in the heart | Q34682797 | ||
| Inhibition of AMP-activated protein kinase α (AMPKα) by doxorubicin accentuates genotoxic stress and cell death in mouse embryonic fibroblasts and cardiomyocytes: role of p53 and SIRT1. | Q35868154 | ||
| Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure | Q35964249 | ||
| Acetaminophen attenuates doxorubicin-induced cardiac fibrosis via osteopontin and GATA4 regulation: reduction of oxidant levels | Q37086060 | ||
| The emerging role of microRNAs in cardiac remodeling and heart failure | Q37319218 | ||
| MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. | Q37328435 | ||
| Distinct mechanisms of cardiomyocyte apoptosis induced by doxorubicin and hypoxia converge on mitochondria and are inhibited by Bcl-xL | Q37580188 | ||
| MicroRNAs: redefining mechanisms in cardiac disease | Q37833881 | ||
| Developing microRNA therapeutics: approaching the unique complexities. | Q38036732 | ||
| The emerging role of miR-208a in the heart | Q38057365 | ||
| Requirement for pre-existing of p21 to prevent doxorubicin-induced apoptosis through inhibition of caspase-3 activation | Q40243606 | ||
| Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation | Q40363652 | ||
| Cooperative interaction between GATA5 and NF-ATc regulates endothelial-endocardial differentiation of cardiogenic cells. | Q40712783 | ||
| Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways | Q44822086 | ||
| Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice | Q46597560 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | doxorubicin | Q18936 |
| microRNA | Q310899 | ||
| P304 | page(s) | 597032 | |
| P577 | publication date | 2015-06-07 | |
| P1433 | published in | Oxidative medicine and cellular longevity | Q26840015 |
| P1476 | title | MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction | |
| P478 | volume | 2015 |
| Q36409311 | Comment on "MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction" |
| Q90451191 | Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p |
| Q48141841 | Doxorubicin and Liposomal Doxorubicin Differentially Affect Expression of miR-208a and let-7g in Rat Ventricles and Atria. |
| Q64262548 | Effects of microRNA-208a on inflammation and oxidative stress in ketamine-induced cardiotoxicity through Notch/NF-κB signal pathways by CHD9 |
| Q58701776 | Ghrelin Alleviates Angiotensin II-Induced H9c2 Apoptosis: Impact of the miR-208 Family |
| Q60960509 | Keeping the Heart Fitm2 during Chemotherapy |
| Q33733403 | MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine |
| Q92763592 | MicroRNA-129-1-3p protects cardiomyocytes from pirarubicin-induced apoptosis by down-regulating the GRIN2D-mediated Ca2+ signalling pathway |
| Q47204916 | MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2. |
| Q90461158 | MicroRNAs in Cancer Treatment-Induced Cardiotoxicity |
| Q39304689 | MicroRNAs in injury and repair |
| Q58559062 | Non-coding RNAs: potential regulators in cardio-oncology |
| Q97643665 | Noncoding RNAs in doxorubicin-induced cardiotoxicity and their potential as biomarkers and therapeutic targets |
| Q52663010 | Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress. |
| Q26747609 | Regulatory mechanisms of microRNA expression |
| Q27319491 | RhNRG-1β Protects the Myocardium against Irradiation-Induced Damage via the ErbB2-ERK-SIRT1 Signaling Pathway |
| Q47929107 | Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients. |
| Q47947947 | Role of noncoding RNAs in regulation of cardiac cell death and cardiovascular diseases |
| Q41983421 | Sarco"MiR" friend or foe: a perspective on the mechanisms of doxorubicin-induced cardiomyopathy |
| Q61812334 | miR-499-5p Attenuates Mitochondrial Fission and Cell Apoptosis via p21 in Doxorubicin Cardiotoxicity |
Search more.